Showing 351-360 of 20873 results for "".
- Urolithin C alleviates Pancreatic β-Cell Dysfunction in Type 1 Diabetes by Activating Nrf2 Signalinghttps://reachmd.com/news/urolithin-c-alleviates-pancreatic-cell-dysfunction-in-type-1-diabetes-by-activating-nrf2-signaling/2457377/Type 1 diabetes (T1D) is an autoimmune disorder that destroys insulin-generating pancreatic β-cells. Preserving pancreatic β-cell function is important for treating T1D. Our study aims to explore the mechanism underlying urolithin C (UC)-mediated regulation of β-cell function.
- 13 New Biomarkers Could Help Better Predict Heart Disease Risk in People with Type 2 Diabeteshttps://reachmd.com/news/13-new-biomarkers-could-help-better-predict-heart-disease-risk-in-people-with-type-2-diabetes/2456995/An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The analysis, conducted by 23 experts from 11 countries, was led by The Johns Hopkins University in the United
- In Patients with NAFLD, Type 2 Diabetes Significantly Ups Risk for Hepatic Decompensation, Hepatocellular Carcinomahttps://reachmd.com/news/in-patients-with-nafld-type-2-diabetes-significantly-ups-risk-for-hepatic-decompensation-hepatocellular-carcinoma/2451795/In individuals with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D), the risk of hepatic decompensation and hepatocellular carcinoma (HCC) at 5 years was more than 3-fold greater than among those without T2D, according to new data from an int
- Exercise: A Vital Tool for Mitigating Diabetes Risk in Greenlandhttps://reachmd.com/news/exercise-a-vital-tool-for-mitigating-diabetes-risk-in-greenland/2470949/What's New New research identifies that exercise can improve insulin sensitivity in the muscles of Greenlandic Inuit individuals carrying a genetic variant that predisposes them to type 2 diabetes. Significance This discovery is significant because i
- Insulin Resistance: Bridging Diabetes Management and Cognitive Healthhttps://reachmd.com/news/insulin-resistance-bridging-diabetes-management-and-cognitive-health/2475484/As insulin resistance remains a significant concern in diabetes management, its role in cognitive health highlights an emerging area for interdisciplinary research and clinical strategy. For clinicians treating type 2 diabetes, convent
- GLP-1 Receptor Agonists Linked to Reduced Psoriasis Treatment Escalation in Type 2 Diabetics: Analysishttps://reachmd.com/news/glp-1-receptor-agonists-linked-to-reduced-psoriasis-treatment-escalation-in-type-2-diabetics-analysis/2487939/Adults with psoriasis and type 2 diabetes mellitus (T2DM) treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were less likely to require escalation of psoriasis therapy than patients receiving most other antihyperglycemic medications, according to
- Bariatric Surgery Outperforms GLP-1 Drugs in Slowing Kidney Disease Progression in Type 2 Diabeticshttps://reachmd.com/news/bariatric-surgery-outperforms-glp-1-drugs-in-slowing-kidney-disease-progression-in-type-2-diabetics/2468555/A recent study conducted by the Cleveland Clinic has revealed that bariatric surgery offers substantial kidney-protective benefits for patients with type 2 diabetes, obesity, and chronic kidney disease (CKD) compared to treatment with GLP-1 receptor agonist medications. Published in Annals of
- Study Finds Causal Links Between Type 1 Diabetes and Key Autoimmune Skin Diseaseshttps://reachmd.com/news/study-finds-causal-links-between-type-1-diabetes-and-key-autoimmune-skin-diseases/2467454/China: A recent study has unveiled significant associations between type 1 diabetes mellitus (T1DM) and various autoimmune skin diseases, employing Mendelian randomization (MR) to elucidate these links. This research, published in Heliyon Journal, highlights the potential for genet
- Incretin Therapies in Type 1 Diabetes: Reappraisal and Geriatric Considerationshttps://reachmd.com/news/incretin-therapies-in-type-1-diabetes-reappraisal-and-geriatric-considerations/2485909/A narrative review in Diabetology synthesizes experimental, clinical trial, and real-world evidence on incretin hormones (GLP-1 and GIP) and incre
- Advancing Maternal Care: Automated Insulin Systems in Type 1 Diabeteshttps://reachmd.com/news/advancing-maternal-care-automated-insulin-systems-in-type-1-diabetes/2484481/Automated closed-loop insulin delivery increased time in pregnancy glucose targets by roughly three hours per day in a randomized multicenter trial